Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome
Chun-Hou Liao, Hann-Chorng Kuo
Int Neurourol J. 2015;19(4):213-219.   Published online 2015 Dec 28
Citations to this article as recorded by
  Crossref logo
Current optimal pharmacologic therapies for overactive bladder
Yuan-Hong Jiang, Hann-Chorng Kuo
Expert Opinion on Pharmacotherapy.2023; 24(18): 2005.     CrossRef
Novel botulinum neurotoxin-A tibial nerve perineural injection to alleviate overactive bladder symptoms in male rats
Seungbeom Kim, Hyun Seok Na, Jong Mok Park, Jin Wook Kim
Animal Cells and Systems.2022; 26(6): 283.     CrossRef
Medical treatment of female overactive bladder syndrome and treatment-related effects
Sheng-Mou Hsiao, Ho-Hsiung Lin
Journal of the Formosan Medical Association.2018; 117(10): 871.     CrossRef
Managing urinary incontinence in women - a review of new and emerging pharmacotherapy
Riccardo Bientinesi, Emilio Sacco
Expert Opinion on Pharmacotherapy.2018; 19(18): 1989.     CrossRef
Long-term follow-up of intravesical botulinum toxin-A injections in women with idiopathic overactive bladder symptoms
T. A. T. Marcelissen, M. S. Rahnama’i, A. Snijkers, B. Schurch, P. De Vries
World Journal of Urology.2017; 35(2): 307.     CrossRef
La disfunción del tracto urinario inferior en el paciente mayor
Carlos Verdejo, Santiago Méndez, Jesús Salinas
Medicina Clínica.2016; 147(10): 455.     CrossRef
Botulinun A toxin urethral sphincter injection for neurogenic or nonneurogenic voiding dysfunction
Hann-Chorng Kuo
Tzu Chi Medical Journal.2016; 28(3): 89.     CrossRef
New pharmacotherapy for treating overactive bladder: mirabegron and botulinum toxin
Tae Heon Kim, Kyu-Sung Lee
Journal of the Korean Medical Association.2016; 59(10): 795.     CrossRef
Urinary tract dysfunction in older patients
Carlos Verdejo, Santiago Méndez, Jesús Salinas
Medicina Clínica (English Edition).2016; 147(10): 455.     CrossRef